Found: 23
Select item for more details and to access through your institution.
Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S510, doi. 10.1093/cid/ciac672
- By:
- Publication type:
- Article
Spotted-fever group Rickettsia in Dermacentor variabilis, Maryland.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Indoleamides are active against drug-resistant Mycobacterium tuberculosis.
- Published in:
- Nature Communications, 2013, v. 4, n. 12, p. 2907, doi. 10.1038/ncomms3907
- By:
- Publication type:
- Article
Surface Proteome Analysis and Characterization of Surface Cell Antigen (Sca) or Autotransporter Family of Rickettsia typhi.
- Published in:
- PLoS Pathogens, 2012, v. 8, n. 8, p. 1, doi. 10.1371/journal.ppat.1002856
- By:
- Publication type:
- Article
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 3, p. 659, doi. 10.1093/jac/dks421
- By:
- Publication type:
- Article
Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0043429
- By:
- Publication type:
- Article
Gene Expression of Mycobacterium tuberculosis Putative Transcription Factors whiB1-7 in Redox Environments.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0037516
- By:
- Publication type:
- Article
Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0030749
- By:
- Publication type:
- Article
An Anomalous Type IV Secretion System in Rickettsia Is Evolutionarily Conserved.
- Published in:
- PLoS ONE, 2009, v. 4, n. 3, p. 1, doi. 10.1371/journal.pone.0004833
- By:
- Publication type:
- Article
Mycobacterium tuberculosis dysregulates MMP/ TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.
- Published in:
- Journal of Pathology, 2015, v. 235, n. 3, p. 431, doi. 10.1002/path.4432
- By:
- Publication type:
- Article
Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 5, p. E1, doi. 10.1164/rccm.202012-4541oc
- By:
- Publication type:
- Article
Assessment of Clofazimine Activity in a Second-Line Regimen for Tuberculosis in Mice.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 188, n. 5, p. 608, doi. 10.1164/rccm.201304-0753OC
- By:
- Publication type:
- Article
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2013, v. 188, n. 5, p. 600, doi. 10.1164/rccm.201304-0650OC
- By:
- Publication type:
- Article
Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 8, p. 1, doi. 10.1371/journal.pntd.0006728
- By:
- Publication type:
- Article
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2017, v. 72, n. 8, p. 2320, doi. 10.1093/jac/dkx152
- By:
- Publication type:
- Article
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.
- Published in:
- 2017
- By:
- Publication type:
- journal article
An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of Clofazimine.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 17, doi. 10.3390/pharmaceutics14010017
- By:
- Publication type:
- Article
Quantitative Analysis of the Phase Transition Mechanism Underpinning the Systemic Self-Assembly of a Mechanopharmaceutical Device.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 1, p. 15, doi. 10.3390/pharmaceutics14010015
- By:
- Publication type:
- Article
Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis Treatment.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 3, p. 512, doi. 10.1093/infdis/jit187
- By:
- Publication type:
- Article
Risk of Tuberculosis Reactivation With Tofacitinib (CP-690550).
- Published in:
- Journal of Infectious Diseases, 2012, v. 205, n. 11, p. 1705, doi. 10.1093/infdis/jis269
- By:
- Publication type:
- Article